Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Hypofractionated Radiochemotherapy for Women With Metastatic or Bulky Uterine Cervix Cancer
NCT06331468Phase 2Recruiting
- Start
- Jun 2025
- Primary completion
- Jul 2028
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC). Started Jun 2025; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT06331468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06331468.